Clinical Utility of Personalised Medicine is a paper published by the NHMRC to explain one of the most significant outcomes of the acceleration in genomic science. Personalised medicine is defined as "the capacity to predict disease development and influence decisions about lifestyle choices or to tailor medical practice to an individual." This includes targeting drugs and treatments based on a detailed understanding of the genetic bases of disease. In addition to the promise of improved patient care and disease prevention, personalised medicine has the potential to lower the ever increasing cost of health care.
NHMRC has developed this paper with the assistance of its Human Genetics Advisory Committee (HGAC) to support health professionals in understanding the applications, utility and limitations of personalised medicine in clinical care.
No comments:
Post a Comment